Last updated on April 2018

Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC


Brief description of study

Primary end points:

This clinical trial is aimed to analyze the effectiveness of Levonorgestrel-Releasing Intrauterine System (LNG-IUS, Mirena) in the fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma, including pathology response and pregnancy outcome.

Second end points:

To analyze the appearances of side-effects.

Clinical Study Identifier: NCT03463252

Contact Investigators or Research Sites near you

Start Over

Zheng Ying, professor

West China Second University Hospital
Chengdu, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.